Randomized trial of α-interferon or dexamethasone as maintenance treatment for multiple myeloma

American Journal of Hematology

Volumn 65, Issue 3, 2000, Pages 204-209

  Alexanian, Raymond ^a,b   Weber, Donna ^a   Dimopoulos, Meletios ^a   Delasalle, Kay ^a   Smith, Terry L ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

interferon; Dexamethasone; Multiple myeloma

Indexed keywords

DEXAMETHASONE; RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FATIGUE; FLUSHING; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; INSOMNIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RELAPSE; REMISSION; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DEXAMETHASONE; HUMANS; INTERFERON-ALPHA; MIDDLE AGED; MULTIPLE MYELOMA;

EID: 0033783964     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200011)65:3<204::AID-AJH5>3.0.CO;2-H     Document Type: Article

References (24)

1. The chemotherapy of plasma-cell myeloma and the incidence of acute leukemia
2. A randomized trial of melphalan and prednisone versus melphalan, prednisone, cyclophosphamide, MeCCNU, and vincristine in untreated multiple myeloma
3. Single, sequential, and multiple alkylating agent therapy for multiple myeloma
4. VAD-based regimen as primary treatment for multiple myeloma
5. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
6. Primary dexamethasone treatment for multiple myeloma
7. Combination therapy with interferon-dexamethasone for newly diagnosed patients with multiple myeloma
8. Maintenance treatment with recombinant interferon α-2b in patients with multiple myeloma responding to conventional induction chemotherapy
9. Interferon α-2b versus no maintenance therapy during the plateau phase in multiple myeloma
10. Randomized trial of interferon maintenance in multiple myeloma
11. Interferon α for induction and maintenance in multiple myeloma
12. Interferon α-2B in addition to melphalan-prednisone for initial and maintenance treatment in multiple myeloma
13. Combination chemotherapy, glucocorticoid, and interferon α in the treatment of multiple myeloma
14. A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon α for maintenance treatment, in multiple myeloma
15. Early myeloablative therapy for multiple myeloma
16. Myeloma protein kinetics following chemotherapy
17. Regression models and life tables
18. HyperCVAD for VAD-resistant multiple myeloma
19. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment
20. Primary therapy of Waldenstrom's macroglobulinemia with 2-chlorodeoxyadenosine
21. Long-term follow-up of patients with chronic lymphocytic leukemia receiving fludarabine regimens as initial therapy
22. High-dose glucocorticoid treatment for resistant myeloma
23. Autotransplants in multiple myeloma
24. Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma